Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial

by Nini de Boer, Sinan Guloksuz, Caroline van Baal, Leonie Willebrands, Jeroen Deenik, Christiaan H. Vinkers, Inge Winter-van Rossum, Janneke Zinkstok, Ingeborg Wilting, Jasper B. Zantvoord, Frank Backx, Wilma E. Swildens, Marieke Schouw, Jan Bogers, Folkwin Hulshof, Rudolf de Knijff, Peter Duindam, Mike Veereschild, Maarten Bak, Geert Frederix, Lieuwe de Haan, Jim van Os, Wiepke Cahn, Jurjen J. Luykx
Published 2021-01-01

To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction...

by Marieke J. H. Begemann, Ilse A. Thompson, Wim Veling, Shiral S. Gangadin, Chris N. W. Geraets, Erna van ‘t Hag, Sanne J. Müller-Kuperus, Priscilla P. Oomen, Alban E. Voppel, Mark van der Gaag, Martijn J. Kikkert, Jim Van Os, H. Filip E. Smit, Rikus H. Knegtering, Sybren Wiersma, Luyken H. Stouten, Harm J. Gijsman, Lex Wunderink, Anton B. P. Staring, Selene R. T. Veerman, Amrita G. S. Mahabir, Jörg Kurkamp, Gerdina H. M. Pijnenborg, Natalie D. Veen, Machteld Marcelis, Koen P. Grootens, Gunnar Faber, Nico J. van Beveren, Agaath Been, Truus van den Brink, Maarten Bak, Therese A. M. J. van Amelsvoort, Andrea Ruissen, Christine Blanke, Karin Groen, Lieuwe de Haan, Iris E. C. Sommer
Published 2020-02-01

Rising co-payments coincide with unwanted effects on continuity of healthcare for patients with schizophrenia in the Netherlands.

by Arnold P M van der Lee, Lieuwe de Haan, Aartjan T F Beekman
Published 2019-01-01

Plasma dopa decarboxylase activity in treatment-resistant recent-onset psychosis patients

by Marieke van der Pluijm, Arjen L. Sutterland, André B. P. van Kuilenburg, Lida Zoetekouw, Lieuwe de Haan, Jan Booij, Elsmarieke van de Giessen
Published 2019-09-01

Schizophrenia in the Netherlands: Continuity of Care with Better Quality of Care for Less Medical Costs.

by Arnold van der Lee, Lieuwe de Haan, Aartjan Beekman
Published 2016-01-01

Discontinuity of psychiatric care for patients with schizophrenia, relation to previous psychiatric care and practice variation between providers: a retrospective longitudinal coho...

by Arnold P. M. van der Lee, Adriaan Hoogendoorn, Lieuwe de Haan, Aartjan T. F. Beekman
Published 2021-06-01

Marked reduction of AKT1 expression and deregulation of AKT1-associated pathways in peripheral blood mononuclear cells of schizophrenia patients.

by Nico J M van Beveren, Gabrielle H S Buitendijk, Sigrid Swagemakers, Lianne C Krab, Christian Röder, Lieuwe de Haan, Peter van der Spek, Ype Elgersma
Published 2012-01-01

Replicated evidence of absence of association between serum S100B and (risk of) psychotic disorder.

by Christine van der Leeuw, Machteld Marcelis, Sanne C T Peeters, Marcel M Verbeek, Paul P C A Menheere, Lieuwe de Haan, Jim van Os, Nico J M van Beveren, Genetic Risk and Outcome in Psychosis (G.R.O.U.P.)
Published 2013-01-01

Economic evaluation of brief cognitive behavioural therapy for social activation in recent-onset psychosis.

by Ben F M Wijnen, Karin Pos, Eva Velthorst, Frederike Schirmbeck, Hoi Yau Chan, Lieuwe de Haan, Mark van der Gaag, Silvia M A A Evers, Filip Smit
Published 2018-01-01

Individualized prediction of three- and six-year outcomes of psychosis in a longitudinal multicenter study: a machine learning approach

by Jessica de Nijs, Thijs J. Burger, Ronald J. Janssen, Seyed Mostafa Kia, Daniël P. J. van Opstal, Mariken B. de Koning, Lieuwe de Haan, GROUP investigators, Wiepke Cahn, Hugo G. Schnack
Published 2021-07-01